SCHEMBL6977597

SCHEMBL6977597

CC(C)(C)[Si](C)(C)N1C(=O)CC1[C@@H](S)c1ncccn1

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
IDH1 O75874 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6975816 0.76 KMT2A (0.37)
SCHEMBL6975819 0.76 KMT2A (0.37)
SCHEMBL14456031 0.74 PIK3CD (0.32) IDH1
SCHEMBL765766 0.74 PIK3CD (0.32) IDH1
SCHEMBL6977046 0.71 IDH1 (0.32) IDH1
SCHEMBL6977048 0.71 IDH1 (0.32) IDH1
SCHEMBL6977778 0.70 NPC1 (0.31)
SCHEMBL11093784 0.68
SCHEMBL10414801 0.68 MAPT (0.33)
SCHEMBL10540453 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1023265-B1 AZETIDINONE DERIVATIVES FOR THE TREATMENT OF HCMV INFECTIONS BOEHRINGER INGELHEIM CA LTD (CA) 2003-01-15 EP disclosed
US-6211170-B1 Azetidinone derivatives for the treatment of HCMV infections BOEHRINGER INGELHEIM (CANADA) LTD. (CA) 2001-04-03 US disclosed